Compare DAN & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAN | STVN |
|---|---|---|
| Founded | 1904 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.9B |
| IPO Year | 2003 | 2021 |
| Metric | DAN | STVN |
|---|---|---|
| Price | $23.17 | $13.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 13 |
| Target Price | ★ $35.67 | $19.46 |
| AVG Volume (30 Days) | ★ 1.6M | 1.0M |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.01% | 0.45% |
| EPS Growth | N/A | N/A |
| EPS | ★ 10.18 | N/A |
| Revenue | ★ $7,500,000,000.00 | N/A |
| Revenue This Year | $4.24 | $6.89 |
| Revenue Next Year | $39.88 | $2.39 |
| P/E Ratio | ★ $2.35 | $27.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.96 | $12.05 |
| 52 Week High | $39.56 | $24.01 |
| Indicator | DAN | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 38.14 | 27.56 |
| Support Level | N/A | $13.28 |
| Resistance Level | $28.05 | $17.19 |
| Average True Range (ATR) | 1.40 | 1.03 |
| MACD | -0.14 | -0.48 |
| Stochastic Oscillator | 29.19 | 21.71 |
Dana Inc is provider of products to virtually every vehicle manufacturer in the world. Its technologies include drive systems (axles, driveshafts and transmissions); electrodynamic technologies (motors, inverters, software and control systems, battery-management systems, and fuel cell plates); sealing solutions (gaskets, seals, cam covers, and oil pan modules); thermal-management technologies (transmission and engine oil cooling, battery and electronics cooling, charge air cooling, and thermal-acoustical protective shielding); and digital solutions (active and passive system controls and descriptive and predictive analytics). The company has two operating segments: Light Vehicle and Commercial Vehicle. The Light Vehicles segment generates the majority of revenue.
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.